Cargando…

Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden

This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiadaliri, Aliasghar A., Gerdtham, Ulf-G, Eliasson, Björn, Gudbjörnsdottir, Soffia, Svensson, Ann-Marie, Steen Carlsson, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053909/
https://www.ncbi.nlm.nih.gov/pubmed/24810579
http://dx.doi.org/10.3390/ijerph110504939
_version_ 1782320465460592640
author Kiadaliri, Aliasghar A.
Gerdtham, Ulf-G
Eliasson, Björn
Gudbjörnsdottir, Soffia
Svensson, Ann-Marie
Steen Carlsson, Katarina
author_facet Kiadaliri, Aliasghar A.
Gerdtham, Ulf-G
Eliasson, Björn
Gudbjörnsdottir, Soffia
Svensson, Ann-Marie
Steen Carlsson, Katarina
author_sort Kiadaliri, Aliasghar A.
collection PubMed
description This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistical analysis. Lower HU was found for female gender, younger age at diagnosis, higher BMI, and history of complications. Microvascular and macrovascular complications had the most negative effect on HU among women and men, respectively. The greatest decline in HU was associated with kidney disorders (−0.114) using the UK tariff and stroke (−0.059) using the Swedish tariff. Multiple stroke and non-acute ischaemic heart disease had higher negative effect than a single event. With the UK tariff, each year elapsed since the last microvascular/macrovascular complication was associated with 0.013 and 0.007 units higher HU, respectively. We found important heterogeneities in effects of complications on HU in terms of gender, multiple event, and time. The Swedish tariff gave smaller estimates and so may result in less cost-effective interventions than the UK tariff. These results suggest that incorporating subgroup-specific HU in cost-utility analyses might provide more insight for informed decision-making.
format Online
Article
Text
id pubmed-4053909
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40539092014-06-12 Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden Kiadaliri, Aliasghar A. Gerdtham, Ulf-G Eliasson, Björn Gudbjörnsdottir, Soffia Svensson, Ann-Marie Steen Carlsson, Katarina Int J Environ Res Public Health Article This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistical analysis. Lower HU was found for female gender, younger age at diagnosis, higher BMI, and history of complications. Microvascular and macrovascular complications had the most negative effect on HU among women and men, respectively. The greatest decline in HU was associated with kidney disorders (−0.114) using the UK tariff and stroke (−0.059) using the Swedish tariff. Multiple stroke and non-acute ischaemic heart disease had higher negative effect than a single event. With the UK tariff, each year elapsed since the last microvascular/macrovascular complication was associated with 0.013 and 0.007 units higher HU, respectively. We found important heterogeneities in effects of complications on HU in terms of gender, multiple event, and time. The Swedish tariff gave smaller estimates and so may result in less cost-effective interventions than the UK tariff. These results suggest that incorporating subgroup-specific HU in cost-utility analyses might provide more insight for informed decision-making. MDPI 2014-05-07 2014-05 /pmc/articles/PMC4053909/ /pubmed/24810579 http://dx.doi.org/10.3390/ijerph110504939 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Kiadaliri, Aliasghar A.
Gerdtham, Ulf-G
Eliasson, Björn
Gudbjörnsdottir, Soffia
Svensson, Ann-Marie
Steen Carlsson, Katarina
Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title_full Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title_fullStr Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title_full_unstemmed Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title_short Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
title_sort health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053909/
https://www.ncbi.nlm.nih.gov/pubmed/24810579
http://dx.doi.org/10.3390/ijerph110504939
work_keys_str_mv AT kiadalirialiasghara healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden
AT gerdthamulfg healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden
AT eliassonbjorn healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden
AT gudbjornsdottirsoffia healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden
AT svenssonannmarie healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden
AT steencarlssonkatarina healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden